The goal of this project is to analyze the factors that control the differentiation of naive CD4+ T-cells into effector subsets with restricted cytokine profiles, and the cellular and biochemical mechanisms of this differentiation process. The proposed studies are based on the hypothesis that CD4+ T-cell differentiation may be divided into an induction phase, in which exogenous cytokines regulate cytokine gene transcription in antigen-stimulated T-cells, and an amplification phase, in which antigen-presenting cells (APCs) and other cytokines expand or suppress differentiation T-cells. Antigen itself may act in both phases, by regulating the pattern of cytokine production and by inducing selective growth or tolerance of particular subsets. Based on this hypothesis, the application proposes the following specific aims to address the major unresolved questions about CD4+ T-cell differentiation.
Specific Aim 1 proposes to study the differentiation of T lymphocytes in vivo. The factors that regulate CD4+ T-cell differentiation in vivo will be studied in normal and T-cell receptor (TCR) transgenic mice immunized in ways that give rise to Th1- or Th2- dominant responses. The roles of cytokines will be examined by immunohistochemistry, and by regulating T-cell differentiation with recombinant cytokines and specific antagonists. The roles of APCs will be studied in B-cell-deficient mice, and of costimulators in mice treated with soluble CTLA4. The relationship between antigen-induced tolerance and selective differentiation to one subset will be examined.
Specific Aim 2 proposes to study the mechanisms of T-cell differentiation in vitro. The effects of exogenous cytokines, APCs, costimulators, and antigens on cytokine gene transcription in antigen or SEB-stimulated T- cells will be examined. The mechanisms of transcriptional control of cytokine genes will be studied, with special emphasis on analysis of transcription factors. Model antigens and peptide analogs will be used to selectively regulate expansion or induce tolerance in differentiating Th1- or Th2-like cells. Thus, this application uses a combination of established and novel in vitro and in vivo model systems to study fundamental questions about T-cell differentiation and the physiologic functions of selected cytokines. Elucidating the mechanisms of CD4+ T- cell differentiation is the key to designing rational approaches for selectively augmenting or suppressing particular T-cell subsets in infectious, allergic, and autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37AI025022-11
Application #
2722913
Study Section
Special Emphasis Panel (NSS)
Program Officer
Ridge, John P
Project Start
1987-07-01
Project End
1999-09-30
Budget Start
1999-04-01
Budget End
1999-09-30
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Sarween, Nadia; Chodos, Anna; Raykundalia, Chandra et al. (2004) CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol 173:2942-51
Andres, Pietro G; Howland, Kimberly C; Dresnek, Douglas et al. (2004) CD28 signals in the immature immunological synapse. J Immunol 172:5880-6
Walker, Lucy S K; Chodos, Anna; Eggena, Mark et al. (2003) Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 198:249-58
Walker, Lucy S K; Ausubel, Lara J; Chodos, Anna et al. (2002) CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen. J Immunol 169:6202-9
Ausubel, Lara J; Chodos, Anna; Bekarian, Nyree et al. (2002) Functional tolerance is maintained despite proliferation of CD4 T cells after encounter with tissue-derived antigen. Dev Immunol 9:173-6
Kane, L P; Andres, P G; Howland, K C et al. (2001) Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol 2:37-44
Howland, K C; Ausubel, L J; London, C A et al. (2000) The roles of CD28 and CD40 ligand in T cell activation and tolerance. J Immunol 164:4465-70
London, C A; Lodge, M P; Abbas, A K (2000) Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 164:265-72
Dahl, A M; Klein, C; Andres, P G et al. (2000) Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes. J Exp Med 191:2031-8
London, C A; Perez, V L; Abbas, A K (1999) Functional characteristics and survival requirements of memory CD4+ T lymphocytes in vivo. J Immunol 162:766-73

Showing the most recent 10 out of 30 publications